Penwest Pharmaceuticals (PPCO) Reports In-Line Q3 Loss of $0.23
Tweet Send to a Friend
Penwest Pharmaceuticals Co. (Nasdaq: PPCO) reports Q3 loss of $0.23, in-line ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
